Trademark: 90894329
Word
ENTOS
Status
Registered
Status Code
700
Status Date
Tuesday, August 29, 2023
Serial Number
90894329
Registration Number
7151783
Registration Date
Tuesday, August 29, 2023
Mark Type
4000
Filing Date
Friday, August 20, 2021
Published for Opposition
Tuesday, October 25, 2022

Trademark Owner History
ENTOS PHARMACEUTICALS INC. -
Entos, Inc. - Original Registrant

Classifications
42 research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; scientific and technological services, namely, research and design in the field of computational chemistry, machine learning and artificial intelligence for use in chemistry, biology, physics, biochemistry, chemical engineering, and computer science, and design and optimization of molecules, materials, and drugs; chemistry services, namely, laboratory research in the fields of chemistry and design of new chemistry; chemistry services in the nature of drug, and molecular discovery services, and product development services; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drug, materials, and molecular development; technical data analysis services being technology advisory services relating to computer programs for use in chemistry, biology, physics, biochemistry, chemical engineering, computer science, and the discovery of new molecules, materials, drugs, and machine learning techniques; computer programming in the fields of molecular, materials, and drug development; computer consultancy services being computer software consultation in the field of drug, materials, and molecular development; computer software consultation services, namely, assistance and consulting in connection with the development of computer applications, databases and systems for use in the field of drug, materials, and molecular development; consulting services in the design and implementation of computer-based information systems for business, namely, provision of online information relating to computer hardware and software design in the field of drug, materials, and molecular development; creation, maintenance, hosting, and design of websites in the field of drug, materials, and molecular development; provision of online non-downloadable software for simulations for drug, materials, and molecular discovery; software as a service (saas) services featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; platform as a service (paas) featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; creating website based indexes of information for others using information technology for use in the field of drug, materials, and molecular development; computer graphics design services, namely, realization of computer graphics and digital imaging for use in the field of drug, materials, and molecular development; scientific research in connection with computerized automation of technical processes for use in the field of drug, materials, and molecular development; cloud-based computing featuring software for optimizing the development of new molecules and designing and discovering molecules, drugs, battery materials, and other molecular products
The English translation of ENTOS in the mark is WITHIN.

Trademark Events
Sep 1, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Sep 1, 2023
Teas Change Of Correspondence Received
Sep 1, 2023
Teas Change Of Domestic Representatives Address
Sep 1, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 1, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 1, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 1, 2023
Teas Change Of Owner Address Received
Aug 30, 2023
Automatic Update Of Assignment Of Ownership
Aug 29, 2023
Notice Of Registration Confirmation Emailed
Aug 29, 2023
Registered-Principal Register
Jul 27, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Jul 26, 2023
Allowed Principal Register - Sou Accepted
Jul 25, 2023
Statement Of Use Processing Complete
Jun 30, 2023
Use Amendment Filed
Jul 24, 2023
Case Assigned To Intent To Use Paralegal
Jun 30, 2023
Teas Statement Of Use Received
Jun 13, 2023
Noa E-Mailed - Sou Required From Applicant
May 4, 2023
Extension Of Time To Oppose Process - Terminated
Oct 27, 2022
Extension Of Time To Oppose Received
Oct 25, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 25, 2022
Published For Opposition
Oct 5, 2022
Notification Of Notice Of Publication E-Mailed
Sep 20, 2022
Approved For Pub - Principal Register
Sep 17, 2022
Teas/Email Correspondence Entered
Sep 16, 2022
Correspondence Received In Law Office
Sep 16, 2022
Teas Response To Office Action Received
May 23, 2022
Notification Of Non-Final Action E-Mailed
May 23, 2022
Non-Final Action E-Mailed
May 23, 2022
Non-Final Action Written
May 23, 2022
Assigned To Examiner
Oct 7, 2021
New Application Office Supplied Data Entered
Sep 8, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 8, 2021
Teas Change Of Correspondence Received
Sep 8, 2021
Teas Change Of Owner Address Received
Aug 24, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24